---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-189147"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:14:40.557252+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q2 GAAP EPS $7.79, adj. EPS $9.04; raises FY2023 guidance

## Summary
- Q2 GAAP net income $7.79/sh, adjusted $9.04/sh; operating revenue $43.4B (+12.7% YoY).
- Medical enrollment 48.0M, up 938k YoY; benefit expense ratio improved 70 bps to 86.4%.
- Health Benefits operating gain $2.1B (+21% YoY); Carelon operating gain $632M (+6.8%).
- Raises FY2023 outlook: GAAP EPS >$29.09, adjusted >$32.85.
- Declares Q3 dividend $1.48/sh; repurchased 1.4M shares for $646M in Q2.

## SEC filing metadata
- accession: 0001193125-23-189147
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/0001193125-23-189147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/d528939d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-189147
- JSON: https://secwatch.observer/filing/0001193125-23-189147.json
- Plain text: https://secwatch.observer/filing/0001193125-23-189147.txt

## Key facts
- Earnings Releases
  Elevance Health, Inc. reported 2023 results: EPS GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share. Guidance raised.
  - Period: 2023
  - EPS: GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share
  - Guidance: raised
  - Result: guidance update
  source text: Given the strong performance in the first half of the year and momentum across Elevance Health, we now expect GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/0001193125-23-189147-index.htm
- Earnings Releases
  Elevance Health, Inc. reported the quarter ended June 30, 2023 results: revenue $43.4 billion, EPS $7.79 per share.
  - Period: the quarter ended June 30, 2023
  - Revenue: $43.4 billion
  - EPS: $7.79 per share
  - Result: reported results
  source text: Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share. • Operating revenue grew 12.7% year-over-year to $43.4 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523189147/0001193125-23-189147-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.